Literature DB >> 8957141

Sufficient conditions for effective treatment of substance abusing homeless persons.

J B Milby1, J E Schumacher, J M Raczynski, E Caldwell, M Engle, M Michael, J Carr.   

Abstract

Treatment efficacy for homeless substance abusers (primarily crack cocaine) was studied in a randomized control design with subjects (n = 176) assigned to usual care (UC) or an enhanced day treatment program plus abstinent contingent work therapy and housing (EC). Subjects met DSM-III-R criteria for Substance Use Disorder and McKinny Act criteria for homelessness. UC involved weekly individual and group counseling. EC involved a day treatment program consisting of daily attendance, transportation, lunch, manualized psychoeducational groups, and individual counseling. A total of 131 (74.4%) subjects (62 UC and 69 EC) were treated and followed. UC subjects attended 28.5% and EC attended 48.4% of expected treatment during the first 2 months. After 2 months, EC subjects experienced up to 4 months of abstinent contingent work therapy (44.9% of EC subjects) and housing (37.7% of EC subjects), with day treatment available two afternoons per week. Longitudinal Wei-Lachin analyses of medians (reported alcohol use, days homeless and employed) and proportions (cocaine toxicologies) were conducted across 2-, 6-, and 12-month follow-up points. EC had 36% fewer positive cocaine toxicologies at 2-months and 18% fewer at 6-months than UC with regression toward baseline at 12-months. EC had 8 days fewer days of reported alcohol use in the past 30 days, 52 fewer days homeless in the past 60 days, and 10 more days employed in the past 30 days from baseline to the 12-months. UC showed no changes except a temporary increase in employment at 6-months. This is one of the first demonstrations that homeless cocaine abusers can be retained and effectively treated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957141     DOI: 10.1016/s0376-8716(96)01286-0

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  44 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  The impact of managed care on substance abuse treatment services.

Authors:  Todd Olmstead; William D White; Jody Sindelar
Journal:  Health Serv Res       Date:  2004-04       Impact factor: 3.402

3.  Exploring the limits and utility of operant conditioning in the treatment of drug addiction.

Authors:  Kenneth Silverman
Journal:  Behav Anal       Date:  2004

Review 4.  Recent advances in the psychotherapy of addictive disorders.

Authors:  Kathleen M Carroll
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

5.  The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans.

Authors:  Charles E Drebing; E Alice Van Ormer; Christopher Krebs; Robert Rosenheck; Bruce Rounsaville; Lawrence Herz; Walter Penk
Journal:  J Appl Behav Anal       Date:  2005

Review 6.  Behavioral therapies for co-occurring substance use and mood disorders.

Authors:  Kathleen M Carroll
Journal:  Biol Psychiatry       Date:  2004-11-15       Impact factor: 13.382

7.  Does the impact of managed care on substance abuse treatment services vary by provider profit status?

Authors:  Todd A Olmstead; Jody L Sindelar
Journal:  Health Serv Res       Date:  2005-12       Impact factor: 3.402

Review 8.  How can health services effectively meet the health needs of homeless people?

Authors:  Nat M J Wright; Charlotte N E Tompkins
Journal:  Br J Gen Pract       Date:  2006-04       Impact factor: 5.386

9.  Sober housing and motivational interviewing: the Treatment Access Project.

Authors:  Deborah Fisk; Dave Sells; Michael Rowe
Journal:  J Prim Prev       Date:  2007-06-06

10.  Economic cost of the therapeutic workplace intervention added to methadone maintenance.

Authors:  Todd W Knealing; M Christopher Roebuck; Conrad J Wong; Kenneth Silverman
Journal:  J Subst Abuse Treat       Date:  2007-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.